PAB 12.5% 0.7¢ patrys limited

combination trial with agmen

  1. 1,318 Posts.
    lightbulb Created with Sketch. 30
    For those new to PAB and the fight against cancer.

    Multiple power full products that are proving to be safe giving them the leading edge.

    Significant 10 yr survival benefit for PAT SC-1.

    Combination trial to commence shortly or has it already ? with Amgen using PAT SM 6 already proved up and a deal at the end of it. I would have thought after two months into the trial Amgen and Patry's should have enough to go off to sign a deal.

    Remember PAB looked as if it was going to go well over 10cents prior to the cash raising, now they have millions in the bank.

    Low risk, high reward. Management have poured jaw dropping amounts of their own cash in, my opinion the perfect spec stock although pretty de-risked as far as I can see if anyone can see why not please let me know.
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
-0.001(12.5%)
Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $43.28K 6.183M

Buyers (Bids)

No. Vol. Price($)
1 237374 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1732079 8
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.